Visit us at http://www.buckinstitute.org Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, […]
Published on August 2, 2017
A new drug known as D-512 is being developed at New York’s Binghamton University to treat Parkinson’s disease. It promises to limit the progression of Parkinson’s disease while also relieving symptoms more effectively than drugs currently available.About 60,000 Americans… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of […]
Published on August 1, 2017
Visit us at http://www.buckinstitute.org Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, […]
Published on August 1, 2017